Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men

Hypertension

Volumn 31, Issue 3, 1998, Pages 780-786

  Kilander, Lena ^a   Nyman, Håkan ^b   Boberg, Merike ^a   Hansson, Lennart ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure monitoring, ambulatory; Cognition; Diabetes; Insulin resistance

Indexed keywords

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TARGET ORGAN;

EID: 0031951913     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.780     Document Type: Article

References (33)

1. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet. 1992;340:645-648.
2. Skoog I, Nilson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993; 328:153-158.
3. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
4. Hedstrand H. A Study of Middle-Aged Men with Particular Reference to Risk Factors for Cardiovascular Disease. Uppsala, Sweden: Faculty of Medicine, Uppsala University; 1975. Thesis.
5. Lithell H, Åberg H, Selinus I, Hedstrand H. The Primary Preventive Study in Uppsala: fatal and non-fatal myocardial infarction during a 10-year follow-up of a middle-aged male population with treatment of high-risk individuals. Acta Med Scand. 1984;215:403-409.
6. Skarfors E. Risk Factors for Development of Diabetes Melittus, Hypertension and Coronary Heart Disease. Uppsala, Sweden: Faculty of Medicine, Uppsala University; 1989. Thesis.
7. Pollare T, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia. 1988;31:415-420.
8. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979; 28:1039.
9. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Lezak M. Neuropsychological Assessment. 3rd ed. New York, NY: Oxford University Press; 1995.
11. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
12. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37: 1595-1607.
13. Launer LJ, Wind AW, Deeg DJH. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol. 1994;139:803-812.
14. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959-962.
15. Launer LJ, Masakj K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 1995;274:1846-1851.
16. Deleted in proof.
17. Elias MF, Wolf PA, D'Agostmo RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-364.
18. Tun PA, Nathan DM, Perlmuter LC. Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med. 1990;6:731-746.
19. Reaven GM, Thompson LW, Nahum D, Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care. 1990;13:16-21.
20. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia. 1995;38:1096-1102.
21. Kuusisto J, Koivisto K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Riekkinen P, Laakso P. Essential hypertension and cognitive function: the role of hyperinsulinemia. Hypertension. 1993;22: 771-779.
22. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol. 1993;50:162-166.
23. Kano K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension. 1996;27:130-135.
24. Tohgi H, Chiba K, Kimura M. Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. Stroke. 1991;22: 603-608.
25. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
26. Breteler M, van Amerongen N, van Swieten J, Claus J, Grobbee D, van Gijn J, Hofman A, van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. Stroke. 1994;25:1109-1115.
27. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol. 1993;50:818-824.
28. Englund E, Brun A, Gustafson L. A white-matter disease in dementia of Alzheimer's type: clinical and neuropathologial correlates. Int J Geriatr Psychiatry. 1989;4:87-102.
29. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312: 805-808.
30. Miller RE, Shapiro AP, King HE, Ginchereau EH, Hosutt A. Effect of antihypertensive treatment on the behavioral consequences of elevated blood pressure. Hypertension. 1984;6:202-208.
31. Bowen J, Teri L, Kukull W, McCormick W, McCurry S, Larson E. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
32. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
33. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM, Schron E, Wegener V. Impact of the treatment of isolated systolic hypertension on behavioral variables. Arch Intern Med. 1994;154:2154-2160.